Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785484 · ClinicalTrials.gov registry record · NA
Impact of Cigarette Pack Constituent Disclosures
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 784
- Enrollment target
NCT02785484 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 784 participants.
The verdict
NCT02785484, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 784 participants
- Enrollment target
Study Summary
The purpose of this randomized controlled trial is to determine whether constituent disclosures on cigarette packs increase intentions to quit smoking. Previous studies have been informative, but they have evaluated candidate graphic warnings, not constituent disclosures. Furthermore, they typically expose participants to messages in controlled but artificial experimental settings for a short period of time, using much lower frequency and shorter duration of message exposure than found in the real world. This study addresses these issues by evaluating the impact of constituent disclosures by randomly assigning smokers to have their cigarette packs labeled with constituent disclosure messages or cigarette butt littering messages.
Interventions
- OTHER Label with constituent disclosure message
- OTHER Label with litter message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 784 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785484
The ClinicalTrials.gov registry entry for NCT02785484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 784 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Label with constituent disclosure message is the first listed.
NCT02785484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02785484 about?
NCT02785484 is a clinical study titled "Impact of Cigarette Pack Constituent Disclosures". The purpose of this randomized controlled trial is to determine whether constituent disclosures on cigarette packs increase intentions to quit smoking. Previous studies have been informative, but they have evaluated candidate graphic warnings, not constituent disclosures. Furthermore, they typically...
What is the current status of trial NCT02785484?
This trial is currently completed. It is a NA study. The enrollment target is 784 participants. The study started on 2016-09. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02785484?
The interventions under investigation include: Label with constituent disclosure message (OTHER), Label with litter message (OTHER).
Who is sponsoring clinical trial NCT02785484?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.